Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1953 1
1956 2
1957 2
1958 3
1959 3
1960 4
1961 1
1962 3
1963 3
1964 2
1965 1
1966 4
1968 4
1969 6
1970 1
1971 8
1972 9
1973 7
1974 9
1975 11
1976 8
1977 9
1978 10
1979 9
1980 14
1981 18
1982 18
1983 20
1984 14
1985 20
1986 17
1987 23
1988 37
1989 23
1990 35
1991 40
1992 50
1993 62
1994 70
1995 93
1996 109
1997 132
1998 136
1999 131
2000 157
2001 180
2002 187
2003 285
2004 318
2005 408
2006 460
2007 464
2008 605
2009 638
2010 788
2011 945
2012 1113
2013 1310
2014 1462
2015 1625
2016 1726
2017 1885
2018 2147
2019 2384
2020 2856
2021 3214
2022 3703
2023 3654
2024 4202
2025 2684

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36,356 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma.
Zhao SH, Zhu ZM, Yang T, Gao D, Liu LH, Yang W, Wang XB, Zhao YX, Li M, Gao YN, Ma RJ, Yang Y, Li HP, Li L, Ao XL, Xiao XB, Hu CL, Yuan SZ, Ding Y, Chen XL, He JX, Liu Y, Huang WR. Zhao SH, et al. Among authors: yang w. Leukemia. 2025 Jul 12. doi: 10.1038/s41375-025-02658-8. Online ahead of print. Leukemia. 2025. PMID: 40652061 No abstract available.
36,356 results
You have reached the last available page of results. Please see the User Guide for more information.